India covid-19 prevention medicines India

Biocon arm to ramp-up Itolizumab production after DCGI nod for covid-19 treatment

Reading now: 956
www.livemint.com

₹30,000-40,000 per vial, with prices in the black market at about twice the amount.Treatment courses vary, with some being given just one dose, and others a second and final dose 48 hours after the first.In contrast, Biocon Biologics’ itolizumab will be sold under the brand ‘Alzumab’ in 25 ml vials at around ₹8,000 per vial.

An entire course will consist of four vials, with each being given after a week’s interval, leading to the cost of ₹32,000 for the entire course.Shaw said that the company will take steps to prevent black-marketing of the medicine, including taking action against entities found black marketing.The Drug Controller General of India V.G.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA